Develops innovative non-opioid pain relief and immunology therapies for high-value markets with unmet medical needs.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
Centrexion Therapeutics is a biopharmaceutical company focused on developing innovative therapies in two key areas: non-opioid pain relief and immunology. The company strategically builds a portfolio targeting high-value markets with significant unmet medical needs, aiming to transform the treatment of pain and autoimmune diseases.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Centrexion Therapeutics Management Team
Investors
6 Dimensions Capital
ArrowMark Partners
Clough Capital Partners L.P.
Efung Capital
InterWest Partners LLC
New Enterprise Associates Inc (NEA)
Quan Capital
Centrexion Therapeutics Valuations & Financials
View real-time NPM data on Centrexion Therapeutics stock including daily Centrexion Therapeutics stock price estimates, valuation history, and historical share price information. Access Centrexion Therapeutics financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track Centrexion Therapeutics pricing across six independent market signals. Looking for private company due diligence data sources on Centrexion Therapeutics? Get in touch to learn more.
Similar Companies
like Centrexion Therapeutics
Podium
Enterprise Software
Customer messaging platform enabling companies to connect at critical touch points.
Colorescience
Consumer
Develops innovative mineral-based skincare and sun protection products that shield skin from environmental damage and harmful UV rays.
Poseidon Aerospace
Industrials
Transforms air logistics with autonomous cargo aircraft that lower cost per ton‑mile and reach areas beyond standard infrastructure.
Misfits Market
Consumer
Direct-to-consumer online grocer that reduces food waste and makes shopping for sustainable.
Panorays
Cybersecurity
Automated platform that assesses, monitors and manages third-party cybersecurity risks for businesses through comprehensive evaluations.
Hive AI
AI & Machine Learning
A software program company focusing on visual intelligence problems for producing unstructured visual data.
miRecule
Healthcare & Life Sciences
Innovates RNA treatments that target genetic causes to improve outcomes for hard‑to‑treat diseases.
PandaDoc
Enterprise Software
Web-based software that facilitates the creation, sending, organization, and tracking of business proposals.
Stablecore
FinTech
Enables banks to issue stablecoins and digital assets while preserving regulatory compliance.
FAQ
We have answers
Centrexion Therapeutics stock does not trade on public stock exchanges. Centrexion Therapeutics stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Centrexion Therapeutics stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Centrexion Therapeutics Stock does not trade on public stock exchanges. In order to sell Centrexion Therapeutics shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Centrexion Therapeutics does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view Centrexion Therapeutics share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for Centrexion Therapeutics stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Centrexion Therapeutics stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Centrexion Therapeutics stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Centrexion Therapeutics is a private company and has not had an IPO. There is currently no Centrexion Therapeutics IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to Centrexion Therapeutics IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
